Parsons J T, Bova F J, Fitzgerald C R, Mendenhall W M, Million R R
Department of Radiation Oncology, University of Florida College of Medicine, Gainesville.
Int J Radiat Oncol Biol Phys. 1994 Nov 15;30(4):755-63. doi: 10.1016/0360-3016(94)90346-8.
To investigate the risk of radiation-induced optic neuropathy according to total radiotherapy dose and fraction size, based on both retrospective and prospectively collected data.
Between October 1964 and May 1989, 215 optic nerves in 131 patients received fractionated external-beam irradiation during the treatment of primary extracranial head and neck tumors. All patients had a minimum of 3 years of ophthalmologic follow-up (range, 3 to 21 years). The clinical end point was visual acuity of 20/100 or worse as a result of optic nerve injury.
Anterior ischemic optic neuropathy developed in five nerves (at mean and median times of 32 and 30 months, respectively, and a range of 2-4 years). Retrobulbar optic neuropathy developed in 12 nerves (at mean and median times of 47 and 28 months, respectively, and a range of 1-14 years). No injuries were observed in 106 optic nerves that received a total dose of < 59 Gy. Among nerves that received doses of > or = 60 Gy, the dose per fraction was more important than the total dose in producing optic neuropathy. The 15-year actuarial risk of optic neuropathy after doses of > or = 60 Gy was 11% when treatment was administered in fraction sizes of < 1.9 Gy, compared with 47% when given in fraction sizes of > or = 1.9 Gy. The data also suggest an increased risk of optic nerve injury with increasing age.
As there is no effective treatment of radiation-induced optic neuropathy, efforts should be directed at its prevention by minimizing the total dose, paying attention to the dose per fraction to the nerve, and using reduced-field techniques where appropriate to limit the volume of tissues that receive high-dose irradiation.
基于回顾性和前瞻性收集的数据,研究根据总放疗剂量和分次剂量发生放射性视神经病变的风险。
1964年10月至1989年5月期间,131例患者的215条视神经在原发性颅外头颈部肿瘤治疗期间接受了分次外照射。所有患者至少有3年的眼科随访(范围为3至21年)。临床终点为因视神经损伤导致视力降至20/100或更差。
5条神经发生前部缺血性视神经病变(平均和中位时间分别为32个月和30个月,范围为2至4年)。12条神经发生球后视神经病变(平均和中位时间分别为47个月和28个月,范围为1至14年)。106条接受总剂量<59 Gy的视神经未观察到损伤。在接受剂量≥60 Gy的神经中,分次剂量在导致视神经病变方面比总剂量更重要。剂量≥60 Gy后,当分次剂量<1.9 Gy时,15年视神经病变精算风险为11%,而当分次剂量≥1.9 Gy时为47%。数据还表明,随着年龄增长,视神经损伤风险增加。
由于放射性视神经病变没有有效的治疗方法,应通过尽量减少总剂量、关注神经的分次剂量以及在适当情况下使用缩小野技术来限制接受高剂量照射的组织体积,努力预防该病。